Parallel Fluidics provides the LNP Screening Array, a microplate-format consumable designed to integrate lipid nanoparticle (LNP) formulation directly into standard laboratory liquid handlers. The product enables researchers to automate microfluidic mixing, increase formulation throughput, and preserve limited biological inputs without requiring dedicated new instruments.
Subscribe to see Parallel Fluidics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Parallel Fluidics Inc. is a healthtech company headquartered in United States. It has raised at least $12.2M across the 3 funding rounds on record. Its most recent funding round, Seed, raised $7M in November 2024. Xcout tracks 7 named people at Parallel Fluidics Inc., including Josh Gomes (CEO). Xcout recorded 1 job posting from Parallel Fluidics Inc. in the last 90 days.
1 more named person on record for Parallel Fluidics Inc., with roles, board committees and tenure — see the full roster →
At least $12.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $7M | 4 named | |
| Seed | $3.8M | 3 named | |
| SEC Form D filing | $1.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 1 job posting from Parallel Fluidics Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Parallel Fluidics Inc.'s hiring signals →
A few of Parallel Fluidics Inc.'s closest competitors — see the full list of competitors and alternatives →
LBT Innovations develops automated artificial intelligence technology for microbiology laboratories. Its flagship product, the APAS Independence instrument, automates the imaging, analysis, interpretation, and reporting of culture plates for clinical and pharmaceutical applications.
28bio develops a brain-on-a-chip platform that uses tissue engineering, neural interfacing, and AI to capture neurological processes. This platform measures electrophysiology data to help healthcare professionals treat neurological diseases.
IZON Technologies, LLC provides instruments and consumables for the isolation and characterization of nanoparticles, including extracellular vesicles, viruses, and lipid nanoparticles. Its product portfolio features the qEV isolation platform, the Exoid analyzer, and the Pulsoid system, which serve researchers and biopharmaceutical developers in areas such as diagnostics and therapeutics.
PharmaFluidics is a Belgian biotechnology company that develops microchip-based chromatography products, notably its μPAC (micro-pillar array column) technology for high-performance liquid chromatography. Its products serve pharmaceutical and biotech researchers, analytical laboratories, and proteomics applications requiring high-resolution separation and analysis of complex samples.
Infera provides an operating system for laboratories that automates and orchestrates experimental protocols, liquid handling execution, data auditing, and instrument integration. The platform serves research and laboratory facilities seeking to streamline and validate their scientific workflows.
Redbud Labs, Inc. develops automated sample preparation solutions and microfluidic technologies, such as the Redbud NA1 and NAxtract systems, for low- to medium-throughput life science applications.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.